Repligen (FRA:RGN) FCF Yield % : 2.17 (As of Apr. 08, 2025)

View and export this data going back to . Start your Free Trial

What is Repligen FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Repligen's Trailing 12-Month Free Cash Flow is €131.6 Mil, and Market Cap is €5,938.3 Mil. Therefore, Repligen's FCF Yield % for today is 2.17%.

The historical rank and industry rank for Repligen's FCF Yield % or its related term are showing as below:

FRA:RGN' s FCF Yield % Range Over the Past 10 Years
Min: -0.07 Med: 0.6 Max: 2.27
Current: 2.17

During the past 13 years, the highest FCF Yield % of Repligen was 2.27%. The lowest was -0.07%. And the median was 0.60%.

FRA:RGN's FCF Yield % is ranked better than
70.15% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: -2.19 vs FRA:RGN: 2.17

Repligen's FCF Margin % for the quarter that ended in Dec. 2024 was 17.42%.

Repligen FCF Yield % Historical Data

The historical data trend for Repligen's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen FCF Yield % Chart

Repligen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

0.36

0.33

0.41

0.74

1.76

Repligen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															0.71	1.39	1.98	2.10	1.44

Competitive Comparison of Repligen's FCF Yield %

For the Medical Instruments & Supplies subindustry, Repligen's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Repligen's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Repligen's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Repligen's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Repligen FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Repligen's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	136.077	/	7723.8684
	=	1.76%

Repligen's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	27.869	*	4	/	7723.8684
	=	1.44%

Repligen FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Repligen FCF Yield % Related Terms

Thank you for viewing the detailed overview of Repligen's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Repligen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

RGEN:USA RGN:Germany

Address

41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453

Website

https://www.repligen.com

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Repligen Headlines

No Headlines